Related references
Note: Only part of the references are listed.Combining Tumor Microenvironment Modulating Nanoparticles with Doxorubicin to Enhance Chemotherapeutic Efficacy and Boost Antitumor Immunity
Mohammad Ali Amini et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2019)
Combining Tumor Microenvironment Modulating Nanoparticles with Doxorubicin to Enhance Chemotherapeutic Efficacy and Boost Antitumor Immunity
Mohammad Ali Amini et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2019)
Two-Step Targeted Hybrid Nanoconstructs Increase Brain Penetration and Efficacy of the Therapeutic Antibody Trastuzumab against Brain Metastasis of HER2-Positive Breast Cancer
Chunsheng He et al.
ADVANCED FUNCTIONAL MATERIALS (2018)
Incidence, pattern and prognosis of brain metastases in patients with metastatic triple negative breast cancer
Jia Jin et al.
BMC CANCER (2018)
Advances in the systemic treatment of triple-negative breast cancer
J. M. Lebert et al.
CURRENT ONCOLOGY (2018)
Evaluation of phenotypic and functional stability of RAW 264.7 cell line through serial passages
Bartlomiej Taciak et al.
PLOS ONE (2018)
Tumor-associated macrophages in breast cancer: Innocent bystander or important player?
Si-Qi Qiu et al.
CANCER TREATMENT REVIEWS (2018)
Triple-Negative Breast Cancers: Systematic Review of the Literature on Molecular and Clinical Features with a Focus on Treatment with Innovative Drugs
Anna Diana et al.
CURRENT ONCOLOGY REPORTS (2018)
Atezolizumab and Nab-Paclitaxel in Advanced Triple-Negative Breast Cancer
P. Schmid et al.
NEW ENGLAND JOURNAL OF MEDICINE (2018)
Every step of the way: integrins in cancer progression and metastasis
Hellyeh Hamidi et al.
NATURE REVIEWS CANCER (2018)
Nanomedicine Strategies to Target Tumor-Associated Macrophages
Karin Binnemars-Postma et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2017)
Blood-brain barrier-penetrating amphiphilic polymer nanoparticles deliver docetaxel for the treatment of brain metastases of triple negative breast cancer
Chunsheng He et al.
JOURNAL OF CONTROLLED RELEASE (2017)
Spatial Targeting of Tumor-Associated Macrophages and Tumor Cells with a pH-Sensitive Cluster Nanocarrier for Cancer Chemoimmunotherapy
Song Shen et al.
NANO LETTERS (2017)
Tumour-associated macrophages as treatment targets in oncology
Alberto Mantovani et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2017)
Integrin-Targeted Peptide- and Peptidomimetic-Drug Conjugates for the Treatment of Tumors
D. Arosio et al.
RECENT PATENTS ON ANTI-CANCER DRUG DISCOVERY (2017)
Targeting tumor associated macrophages: The new challenge for nanomedicine
Fernando Torres Andon et al.
SEMINARS IN IMMUNOLOGY (2017)
Targeted drug delivery using iRGD peptide for solid cancer treatment
Xiangsheng Liu et al.
MOLECULAR SYSTEMS DESIGN & ENGINEERING (2017)
Dual-targeted hybrid nanoparticles of synergistic drugs for treating lung metastases of triple negative breast cancer in mice
Tian Zhang et al.
ACTA PHARMACOLOGICA SINICA (2017)
The Microenvironmental Landscape of Brain Tumors
Daniela F. Quail et al.
CANCER CELL (2017)
Cellular uptake mechanism and comparative evaluation of antineoplastic effects of paclitaxel-cholesterol lipid emulsion on triple-negative and non-triple-negative breast cancer cell lines
Jun Ye et al.
INTERNATIONAL JOURNAL OF NANOMEDICINE (2016)
A New Method for Evaluating Actual Drug Release Kinetics of Nanoparticles inside Dialysis Devices via Numerical Deconvolution
Yousheng Zhou et al.
JOURNAL OF CONTROLLED RELEASE (2016)
Nanomedicine of synergistic drug combinations for cancer therapy - Strategies and perspectives
Rui Xue Zhang et al.
JOURNAL OF CONTROLLED RELEASE (2016)
Polymer-lipid hybrid nanoparticles synchronize pharmacokinetics of co-encapsulated doxorubicin-mitomycin C and enable their spatiotemporal co-delivery and local bioavailability in breast tumor
Rui Xue Zhang et al.
NANOMEDICINE-NANOTECHNOLOGY BIOLOGY AND MEDICINE (2016)
Metastatic site-specific polarization of macrophages in intracranial breast cancer metastases
Nora Rippaus et al.
ONCOTARGET (2016)
Emerging Strategies for Treating Brain Metastases from Breast Cancer
David P. Kodack et al.
CANCER CELL (2015)
Silencing β3 Integrin by Targeted ECO/siRNA Nanoparticles Inhibits EMT and Metastasis of Triple-Negative Breast Cancer
Jenny G. Parvani et al.
CANCER RESEARCH (2015)
Targeting of metastasis-promoting tumor-associated fibroblasts and modulation of pancreatic tumor-associated stroma with a carboxymethylcellulose-docetaxel nanoparticle
Mark J. Ernsting et al.
JOURNAL OF CONTROLLED RELEASE (2015)
Nanoparticles coated with the tumor-penetrating peptide iRGD reduce experimental breast cancer metastasis in the brain
Amanda M. Hamilton et al.
JOURNAL OF MOLECULAR MEDICINE-JMM (2015)
Periostin secreted by glioblastoma stem cells recruits M2 tumour-associated macrophages and promotes malignant growth
Wenchao Zhou et al.
NATURE CELL BIOLOGY (2015)
RGD-conjugated solid lipid nanoparticles inhibit adhesion and invasion of αvβ3 integrin-overexpressing breast cancer cells
Dan Shan et al.
DRUG DELIVERY AND TRANSLATIONAL RESEARCH (2015)
A Multifunctional Polymeric Nanotheranostic System Delivers Doxorubicin and Imaging Agents across the Blood-Brain Barrier Targeting Brain Metastases of Breast Cancer
Jason Li et al.
ACS NANO (2014)
Ligand-Directed Active Tumor-Targeting Polymeric Nanoparticles for Cancer Chemotherapy
Yinan Zhong et al.
BIOMACROMOLECULES (2014)
Tumor penetrability and anti-angiogenesis using iRGD-mediated delivery of doxorubicin-polymer conjugates
Ke Wang et al.
BIOMATERIALS (2014)
COX-2 Drives Metastatic Breast Cells from Brain Lesions into the Cerebrospinal Fluid and Systemic Circulation
Joshua E. Allen et al.
CANCER RESEARCH (2014)
Tumor-Associated Macrophages: From Mechanisms to Therapy
Roy Noy et al.
IMMUNITY (2014)
Cilengitide combined with standard treatment for patients with newly diagnosed glioblastoma with methylated MGMT promoter (CENTRIC EORTC 26071-22072 study): a multicentre, randomised, open-label, phase 3 trial
Roger Stupp et al.
LANCET ONCOLOGY (2014)
Synergistic Nanoparticulate Drug Combination Overcomes Multidrug Resistance, Increases Efficacy, and Reduces Cardiotoxicity in a Nonimmunocompromised Breast Tumor Model
Adam J. Shuhendler et al.
MOLECULAR PHARMACEUTICS (2014)
Specific Deletion of LDL Receptor-Related Protein on Macrophages Has Skewed In Vivo Effects on Cytokine Production by Invariant Natural Killer T Cells
Roman Covarrubias et al.
PLOS ONE (2014)
Macrophage Regulation of Tumor Responses to Anticancer Therapies
Michele De Palma et al.
CANCER CELL (2013)
Myeloid Cell Receptor LRP1/CD91 Regulates Monocyte Recruitment and Angiogenesis in Tumors
Nicole D. Staudt et al.
CANCER RESEARCH (2013)
Design of pH-responsive nanoparticles of terpolymer of poly(methacrylic acid), polysorbate 80 and starch for delivery of doxorubicin
Alireza Shalviri et al.
COLLOIDS AND SURFACES B-BIOINTERFACES (2013)
αv-Integrin isoform expression in primary human tumors and brain metastases
Alexander Vogetseder et al.
INTERNATIONAL JOURNAL OF CANCER (2013)
Mechanism of polymeric nanoparticle-based drug transport across the blood-brain barrier (BBB)
Joerg Kreuter
JOURNAL OF MICROENCAPSULATION (2013)
Peptides as Targeting Elements and Tissue Penetration Devices for Nanoparticles
Erkki Ruoslahti
ADVANCED MATERIALS (2012)
Accessories to the Crime: Functions of Cells Recruited to the Tumor Microenvironment
Douglas Hanahan et al.
CANCER CELL (2012)
pH-Dependent doxorubicin release from terpolymer of starch, polymethacrylic acid and polysorbate 80 nanoparticles for overcoming multi-drug resistance in human breast cancer cells
Alireza Shalviri et al.
EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS (2012)
RGD-Based Strategies To Target Alpha(v) Beta(3) Integrin in Cancer Therapy and Diagnosis
Fabienne Danhier et al.
MOLECULAR PHARMACEUTICS (2012)
Uptake Mechanism of ApoE-Modified Nanoparticles on Brain Capillary Endothelial Cells as a Blood-Brain Barrier Model
Sylvia Wagner et al.
PLOS ONE (2012)
A Novel Solid Lipid Nanoparticle Formulation for Active Targeting to Tumor αvβ3 Integrin Receptors Reveals Cyclic RGD as A Double-Edged Sword
Adam J. Shuhendler et al.
ADVANCED HEALTHCARE MATERIALS (2012)
The role of the organ microenvironment in brain metastasis
Isaiah J. Fidler
SEMINARS IN CANCER BIOLOGY (2011)
A novel doxorubicin-mitomycin C co-encapsulated nanoparticle formulation exhibits anti-cancer synergy in multidrug resistant human breast cancer cells
Adam J. Shuhendler et al.
BREAST CANCER RESEARCH AND TREATMENT (2010)
Doxorubicin Cardiomyopathy
Kanu Chatterjee et al.
CARDIOLOGY (2010)
Macrophage Diversity Enhances Tumor Progression and Metastasis
Bin-Zhi Qian et al.
CELL (2010)
LDL Receptor-Related Protein 1 Regulates the Abundance of Diverse Cell-Signaling Proteins in the Plasma Membrane Proteome
Alban Gaultier et al.
JOURNAL OF PROTEOME RESEARCH (2010)
Integrins in cancer: biological implications and therapeutic opportunities
Jay S. Desgrosellier et al.
NATURE REVIEWS CANCER (2010)
Tissue-Penetrating Delivery of Compounds and Nanoparticles into Tumors
Kazuki N. Sugahara et al.
CANCER CELL (2009)
Activation of tumor cell integrin αvβ3 controls angiogenesis and metastatic growth in the brain
Mihaela Lorger et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)
Sites of Distant Recurrence and Clinical Outcomes in Patients With Metastatic Triple-negative Breast Cancer High Incidence of Central Nervous System Metastases
Nancy U. Lin et al.
CANCER (2008)
Role of the integrin-binding protein osteopontin in lymphatic metastasis of breast cancer
Alison L. Allan et al.
AMERICAN JOURNAL OF PATHOLOGY (2006)
In vitro toxicity to breast cancer cells of microsphere-delivered mitomycin C and its combination with doxorubicin
RY Cheung et al.
EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS (2006)
Dual functionality of the anti-β1 integrin antibody, 12G10, exemplifies agonistic signalling from the ligand binding pocket of integrin adhesion receptors
JD Humphries et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2005)
The cytoplasmic domain of the low density lipoprotein (LDL) receptor-related protein, but not that of the LDL receptor, triggers phagocytosis
M Patel et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
Apolipoprotein-mediated transport of nanoparticle-bound drugs across the blood-brain barrier
J Kreuter et al.
JOURNAL OF DRUG TARGETING (2002)
Protection of normal proliferating cells against chemotherapy by staurosporine-mediated, selective, and reversible G1 arrest
XM Chen et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2000)
Polysorbate-80 coating enhances uptake of polybutylcyanoacrylate (PBCA)-nanoparticles by human and bovine primary brain capillary endothelial cells
P Ramge et al.
EUROPEAN JOURNAL OF NEUROSCIENCE (2000)
Share Paper
